INS and myotonic dystrophy type 2: In contrast, a randomized control trial (RCT) by Lauritzen et al. revealed that 3 months treatment with 10 mg of melatonin in male DM2 patients decreases the insulin sensitivity, which is the fundamental in pathophysiology of DM2 (23).